Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...